What we’re reading: Alzheimer’s drug receives FDA approval

Alzheimer’s Association Welcomes FDA Approval of Aducanumab

This is the first FDA-approved drug that delays decline due to Alzheimer’s disease. This means individuals may have more time to actively participate in daily life, have sustained independence and hold on to memories longer. We can experience longer — the relationships we hold most dear — our families and friends.